PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
Goddards Muscle lotion
1003020V0BBAAAA
Goddards Turpentine oil Musculoskeletal and Joint Diseases No data available
Golimumab 100mg/1ml inj pre-filled disposable devices
1001030X0AAACAC
Golimumab Golimumab Musculoskeletal and Joint Diseases No data available
Golimumab 50mg/0.5ml inj pre-filled syringes
1001030X0AAAAAA
Golimumab Golimumab Musculoskeletal and Joint Diseases No data available
Gosachew 1500mg chewable tablets
1001050A0BTAAAC
Gosachew Glucosamine hydrochloride (Rheumatic) Musculoskeletal and Joint Diseases No data available
Gosachew 500mg/400mg chewable tablets
1001050A0BTABAD
Gosachew Glucosamine hydrochloride (Rheumatic) Musculoskeletal and Joint Diseases No data available
Gosaveg 750mg tablets
1001050A0BYAAAB
Gosaveg Glucosamine hydrochloride (Rheumatic) Musculoskeletal and Joint Diseases No data available
Hedex Ibuprofen 200mg caplets
1001010J0CPAAAD
Hedex ibuprofen Ibuprofen Musculoskeletal and Joint Diseases No data available
Hedex Ibuprofen 200mg tablets
1001010J0CPABAD
Hedex ibuprofen Ibuprofen Musculoskeletal and Joint Diseases No data available
Higher Nature Vegetarian Glucosamine hydrochloride 800mg tab
1001050A0BIAAAG
Higher Nature (Glucosamine hydrochloride) Glucosamine hydrochloride (Rheumatic) Musculoskeletal and Joint Diseases No data available
Hulio 40mg/0.8ml solution for injection pre-filled pens
1001030S0BDAAAB
Hulio Adalimumab Musculoskeletal and Joint Diseases No data available
Hulio 40mg/0.8ml solution for injection pre-filled syringes
1001030S0BDABAA
Hulio Adalimumab Musculoskeletal and Joint Diseases No data available
Humira 40mg/0.4ml solution for injection pre-filled syringes
1001030S0BBAEAE
Humira Adalimumab Musculoskeletal and Joint Diseases No data available
Humira 40mg/0.8ml solution for injection pre-filled pens
1001030S0BBABAB
Humira Adalimumab Musculoskeletal and Joint Diseases No data available
Humira 40mg/0.8ml solution for injection pre-filled syringes
1001030S0BBAAAA
Humira Adalimumab Musculoskeletal and Joint Diseases No data available
Humira 40mg/0.8ml solution for injection vials
1001030S0BBACAC
Humira Adalimumab Musculoskeletal and Joint Diseases No data available
Humira 80mg/0.8ml solution for injection pre-filled pens
1001030S0BBAHAH
Humira Adalimumab Musculoskeletal and Joint Diseases No data available
Humira 80mg/0.8ml solution for injection pre-filled syringes
1001030S0BBAGAG
Humira Adalimumab Musculoskeletal and Joint Diseases No data available
Hyalase 1500unit powder for solution for injection ampoules
1003010P0BBAAAA
Hyalase Hyaluronidase Musculoskeletal and Joint Diseases No data available
Hyalgan 20mg/2ml solution for injection pre-filled syringes
1003010U0BBAAAA
Hyalgan Hyaluronic acid sodium Musculoskeletal and Joint Diseases No data available
Hydroxychloroquine 108mg/5ml oral solution
1001030C0AABABA
Hydroxychloroquine sulfate Hydroxychloroquine sulfate Musculoskeletal and Joint Diseases No data available
Hydroxychloroquine 120mg/5ml oral liquid
1001030C0AAAVAV
Hydroxychloroquine sulfate Hydroxychloroquine sulfate Musculoskeletal and Joint Diseases No data available
Hydroxychloroquine 150mg/5ml oral liquid
1001030C0AAANAN
Hydroxychloroquine sulfate Hydroxychloroquine sulfate Musculoskeletal and Joint Diseases No data available
Hydroxychloroquine 15mg/5ml oral solution
1001030C0AABCBC
Hydroxychloroquine sulfate Hydroxychloroquine sulfate Musculoskeletal and Joint Diseases No data available
Hydroxychloroquine 160mg/5ml oral solution
1001030C0AAAPAP
Hydroxychloroquine sulfate Hydroxychloroquine sulfate Musculoskeletal and Joint Diseases No data available
Hydroxychloroquine 20mg/5ml oral solution
1001030C0AAAKAK
Hydroxychloroquine sulfate Hydroxychloroquine sulfate Musculoskeletal and Joint Diseases No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.